Back to top
Franklin Strategic Biotechnology Discovery Fund Class A: (MF: FBDIX)
(NASDAQ Mutual Funds) As of May 12, 2025 08:00 PM ET
$108.33 USD
+3.75 (3.59%)
Zacks MF Rank
1-Strong Buy of 5 1
Latest Performance as of Apr 30, 2025
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | -3.46 | 69 |
| 3 months | -6.21 | 51 |
| 6 months | -11.77 | 86 |
| 1 Year | -3.64 | 79 |
| 3 Year | 7.83 | 9 |
| 5 Year | 2.16 | 88 |
| 10 Year | 1.93 | 93 |
* Annual for three years and beyond.
Mutual Funds Research & Tools
Search Similar Mutual Funds
Research similar Mutual Funds with higher ranks and performance ratings.
Mutual Funds Comparison View (minimum of 2)
Mutual Funds Screener
Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.
Portfolio Statistics
| % Unrealized Gain | 33.59 |
| % Yield | 0.00 |
| % SEC Yield | NA |
| Net Assets (Mil $) 4/30/2025 | 542.56 |
| % Turnover 4/30/2025 | 35.87 |
Risk
| 3 Year | 5 Year | 10 Year | |
|---|---|---|---|
| Beta | 0.57 | 0.63 | 0.88 |
| Alpha | -0.14 | -6.99 | -6.92 |
| R Squared | 0.27 | 0.30 | 0.37 |
| Std. Dev. | 17.97 | 18.61 | 22.45 |
| Sharpe | 0.27 | 0.06 | 4.00 |
Sector / Country Weightings
| As of 4/30/2025 | % of Portfolio |
|---|---|
| Health | 74.43 |
| Other | 10.00 |
| Services | 9.70 |
| Technology | 3.02 |
| Industrial Cyclical | 2.32 |
| Retail Trade | 0.33 |
| Finance | 0.20 |
Portfolio Holdings
| Top Equity Holdings (As of 1/31/2025) |
% of Portfolio | Value (Mil$) |
|---|---|---|
| AMGEN INC | 6.65 | 53.35 |
| VERTEX PHARMACEUTICALS IN | 6.60 | 52.97 |
| GILEAD SCIENCES INC | 6.07 | 48.71 |
| REGENERON PHARMACEUTICALS | 5.22 | 41.87 |
| TOTAL*SHORT TERM INVESTME | 5.21 | 41.79 |
| ARGENX SE ADR | 3.77 | 30.23 |
| JAZZ PHARMACEUTICALS PLC | 3.54 | 28.44 |
| NEUROCRINE BIOSCIENCES IN | 3.15 | 25.30 |
| ASCENDIS PHARMA AS ADR | 3.10 | 24.88 |
Stock Holding % of Net Assets
| As Of | 1/31/2025 |
| Total Issues | 81 |
| Avg. P/E | 37.78 |
| Avg. P/Book | 4.67 |
| Avg. EPS Growth | 13.39 |
| Avg. Market Value (Mil $) | 67,479 |
Composition
| % of Portfolio | |
| Stocks | 94.71 |
| Foreign Stocks | 19.27 |
| Cash | 5.21 |
| Bonds | 0.00 |
| Foreign Bonds | 0.00 |
| Preferred | 0.33 |
| Convertible | 1.11 |
| Other | -1.36 |
| Foreign Hedged | 0.00 |
Style Analysis
| % of Portfolio | |
| Large Growth | 0.00 |
| Large Value | 0.00 |
| Small Growth | 11.78 |
| Small Value | 0.00 |
| Foreign Stock | 12.01 |
| Emerging Market | 1.19 |
| Precious Metal | 0.00 |
| Intermediate Bond | 8.51 |
| Foreign Bond | 17.89 |
| High Yield Bond | 0.00 |